Moreover, selective MEK inhibition was also able to significantly block TKI-R CALU-3 cell growth as tumour xenografts in vivo, indicating a key role of the MEK/MAPK pathway in the EMT in this experimental cancer cell system. This evidence concerns the gene MAP2K7 and cancer.